Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 1
2005 1
2007 1
2013 1
2016 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Non-Cutaneous Melanoma"
Page 1
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H, Pedersen L, Nørgaard M, Ulrichsen SP, Thygesen SK, Nelson JJ. Li H, et al. BMC Cancer. 2016 May 3;16:295. doi: 10.1186/s12885-016-2315-0. BMC Cancer. 2016. PMID: 27141983 Free PMC article.
Population-based background rates of cuSCC and non-cutaneous squamous cell carcinoma (non-cuSCC) in the metastatic melanoma population may contextualize safety signals from randomized clinical trials or the clinics. ...RESULTS: The median age at met …
Population-based background rates of cuSCC and non-cutaneous squamous cell carcinoma (non-cuSCC) in the metastatic m …
Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM, Thomas F, VanderWalde A, King B, Wilson M, Pallera AM. Delgado-Ramos GM, et al. Med Oncol. 2019 Jan 21;36(2):17. doi: 10.1007/s12032-018-1230-4. Med Oncol. 2019. PMID: 30666496
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. ...Predictors of mortality were metastasis, age, tumor stage, and headache as a reported symptom. Surveillance successfully diagnosed metastatic disease in most patients. Most patients …
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. ...Predictors of mortality were metastasis, age, tum …
MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP, Williams JD, Allen CM, Prasad ML. Sedghizadeh PP, et al. Med Sci Monit. 2005 Jul;11(7):BR189-94. Epub 2005 Jun 29. Med Sci Monit. 2005. PMID: 15990678
BACKGROUND: A more recently characterized melanocyte-specific gene, MSG-1, has been suggested as having a role in embryogenesis, melanogenesis and melanoma progression. Studies involving MSG-1 have involved cutaneous melanocytic lesions, which are different than non …
BACKGROUND: A more recently characterized melanocyte-specific gene, MSG-1, has been suggested as having a role in embryogenesis, melanogenes …
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma.
Woo TE, Stukalin I, Ding PQ, Goutam S, Sander M, Ewanchuk B, Cheung WY, Heng DYC, Cheng T. Woo TE, et al. Curr Oncol. 2023 Sep 30;30(10):8936-8947. doi: 10.3390/curroncol30100646. Curr Oncol. 2023. PMID: 37887546 Free PMC article.
Patients must have had histologically confirmed locally advanced or metastatic melanoma and had to have received at least one cycle of immunotherapy (single agent nivolumab, pembrolizumab, or combination ipilimumab plus nivolumab). ...There were no significant diffe …
Patients must have had histologically confirmed locally advanced or metastatic melanoma and had to have received at least one …
Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study.
Vijuk G, Coates AS. Vijuk G, et al. Ann Oncol. 1998 Apr;9(4):419-22. doi: 10.1023/a:1008201931959. Ann Oncol. 1998. PMID: 9636833 Free article.
BACKGROUND: Malignant melanoma presents as metastatic disease without an apparent primary in about 4% of cases. These are referred to as occult primary melanoma (OPM). It is not known whether these represent de novo malignant transformation in non-c …
BACKGROUND: Malignant melanoma presents as metastatic disease without an apparent primary in about 4% of cases. These are refe …
A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features.
Hanson IM, Banerjee SS, Menasce LP, Prescott RJ. Hanson IM, et al. Histopathology. 2002 Feb;40(2):187-95. doi: 10.1046/j.1365-2559.2002.01318.x. Histopathology. 2002. PMID: 11952865
METHODS AND RESULTS: Haematoxylin and eosin-stained sections of each case of cutaneous small-cell malignant melanoma, together with locally recurrent skin lesions and, where available, metastatic deposits, were re-examined. ...Non-melanocytic markers were negative. …
METHODS AND RESULTS: Haematoxylin and eosin-stained sections of each case of cutaneous small-cell malignant melanoma, together with l …
Jejuno-jejunal invagination due to intestinal melanoma.
Resta G, Anania G, Messina F, de Tullio D, Ferrocci G, Zanzi F, Pellegrini D, Stano R, Cavallesco G, Azzena G, Occhionorelli S. Resta G, et al. World J Gastroenterol. 2007 Jan 14;13(2):310-2. doi: 10.3748/wjg.v13.i2.310. World J Gastroenterol. 2007. PMID: 17226915 Free PMC article.
Cutaneous melanoma is one of the most studied neoplastic lesions in biology and clinical oncology. It has been well documented that this type of neoplasm presents a high metastatic rate, and is able to involve nearly every tissue. Non-cutaneous mela …
Cutaneous melanoma is one of the most studied neoplastic lesions in biology and clinical oncology. It has been well documented that t …
Medical image. An unusual case of melaena.
Huang J, Cunliffe R. Huang J, et al. N Z Med J. 2013 Nov 22;126(1386):111-3. N Z Med J. 2013. PMID: 24317000
Metastatic melanoma can present with non-cutaneous symptoms even after several years of remission. ...
Metastatic melanoma can present with non-cutaneous symptoms even after several years of remission. ...